Lung Cancer Symptom Assessment and Management Intervention

Lung Cancer Symptom Assessment and Management Intervention

The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).

Inclusion Criteria:

• HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years.
• Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the out-patient setting; receiving treatment with chemotherapy +/- additional therapies; English speaking.

Exclusion Criteria:

• Patients: Any patient who needs emergent care, routine visits scheduled less than once a month